A true collision tumor is a rare entity composed of two histologically distinct neoplasms coinciding in the same organ. This paper reports a unique case of cerebral collision tumor consisting of two benign components. On the first hand, meningioma which is usually a benign lesion arising from the meningothelial cell in the arachnoidal membrane. On the other, cerebral cavernoma which is a well-circumscribed, benign vascular hamartoma within the brain. To our knowledge, there is no previously documented case of cerebral collision tumor consisting of two benign components. A 56-year-old Caucasian male suffered in 2002 from an atypical meningioma WHO II° located in the left lateral ventricle. Three years after the tumor extirpation, the patient suffered from a hematoma in the fourth ventricle due to a recurrently haemorrhaged cavernoma. In 2008, a recurrence of the tumor in the left lateral ventricle was discovered. Additionally, another tumor located in the quadrigeminal lamina was detected. After surgical resection of the tumor in the left lateral ventricle, the pathological examination confirmed the diagnosis of a collision tumor consisting of components of a meningioma WHO II° and a cavernoma. Postoperatively, no adjuvant treatment was needed and no tumor recurrence is discovered up to the present. A possible explanation for the collision of those two different tumors may be migration of tumor cells mediated by the cerebrospinal fluid. After 5-years of follow-up, there is no sign of any tumor recurrence; therefore, surgical tumor removal without adjuvant therapy seems to be the treatment of choice.
INTRODUCTION
A true collision tumor represents a coexistence of two adjacent but histologically different malignant neoplasm's occurring in the same organ without histological admixture or an intermediate cell population zone 11) . Such tumors con- (Fig. 1, 2) . . They account for 14.3-19% of primary intracranial neoplasms; however, unlike nonmalignant tumors elsewhere in the body, these brain tumors can cause disability and may sometimes be life threatening 4) . . When the A B tumor removal is incomplete 5-year recurrence rates of 37-85% are reported 3) . In our case, the first operation resulted in a complete removal of the meningioma. Seven years after the first procedure a recurrent tumor in the posterior horn of the left lateral ventricle was revealed.
In terms of cavernomas, they have several varying labels such as cavernous hemangioma, cavernous angioma, and cavernous malformation; the term cavernoma is often used when referring to presence in the brain. They are well-circumscribed, benign vascular hamartomas consisting of irregular thick and thin walled sinusoidal vascular channels located within the brain. They lack intervening neural parenchyma, large feeding arteries, or large draining veins; usually 1-5 cm in size and the prevalence of multiple occurrence varies between 3% and 50%. They are filled with blood in various stages of thrombus formation. These lesions may arise de novo or after radiation 4) . However, the patient in our case did not get any radiation therapy. Cavernous malformations can occur sporadically or follow an autosomal dominant pattern. Approximately half of them are familial in nature, and they occur multiply in 50% of cases 1) . In our case, the cavernoma appeared after the first removal of the meningioma in the fourth ventricle. After removal, there was no indication of another intracerebral cavernoma.
Without special or unique clinical features, collision tumors are difficult to diagnose preoperatively; pathological identification of the dual components is often the only way to ensure a correct diagnosis.
The pathological examination of the recurrent tumor in our case revealed the diagnosis of a collision tumor, consisting of meningioma and cavernoma components. Although this uncummon diagnosis was confirmed by the German Brain Tumor Reference Center, there is subject for debate. It seems to be difficult to make an unequivocal distinction between an angiomatous meningioma, which is an meningotheliomatous variety with closely packed blood vessels (WHO I°) 4) , and the collision tumor, consisting of meningioma and cavernoma components. The pathological examination including immunohistochemical profile still supports this unique diagnosis.
In the literature, there are only approximately 50 reports of intracranial collision tumors. Most of them describe cases with collision tumors consisting of malignant astrocytoma (including glioblastoma) and meningioma 3, 6, 7, 9, 10) . There are also reports of collision tumors consisting of two different cerebral metastases 2, 8) . In almost all of these cases, the collision tumor consists of at least one malignant entity, but in our case, the collision tumor consists of two benign entities.
However, we must consider that one entity is an atypical meningioma (WHO II°). Interestingly, the meningioma, which potentially can evolve malignancy and malignant growth patterns, was a recurrent tumor after total removal seven years before. Thus, invasive proliferation does not appear to be the reason for the collision.
Our unusual case of a collision tumor consisting of meningioma and cavernoma seems to be a unique collision tumor of the brain. To our knowledge, this is the first reported case of a collision tumor of the brain consisting of two benign entities (meningioma and cavernoma components).
Both tumors were located in the ventricular system. We hy- 
